Yahoo
Shanghai - Delayed Quote CNY

Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)

15.03 -0.27 (-1.76%)
At close: 3:00:00 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
5,284,792.38
5,508,595.17
5,160,584.73
5,523,418.18
5,445,105.15
Cost of Revenue
3,392,949.47
3,478,574.74
3,417,168.67
3,443,493.39
3,557,815.87
Gross Profit
1,891,842.91
2,030,020.44
1,743,416.05
2,079,924.78
1,887,289.28
Operating Expense
806,402.31
796,760.21
842,679.52
859,503.93
773,652.95
Operating Income
1,085,440.61
1,233,260.23
900,736.53
1,220,420.85
1,113,636.33
Net Non Operating Interest Income Expense
-12,147.08
29,460.02
65,332.90
66,616.03
-10,857.17
Pretax Income
767,530.38
919,451.40
730,602.42
1,180,642.04
1,103,821.68
Tax Provision
180,702.44
190,908.28
123,534.91
149,270.26
182,848.20
Net Income Common Stockholders
599,202.94
730,073.37
606,096.35
1,033,255.69
921,170.37
Basic EPS
0.67
0.82
0.68
1.16
1.11
Diluted EPS
0.67
0.82
0.68
1.16
1.11
Basic Average Shares
893,201.86
890,333.38
891,318.16
890,737.66
829,883.22
Diluted Average Shares
893,201.86
890,333.38
891,318.16
890,737.66
829,883.22
Total Operating Income as Reported
772,419.26
924,945.26
732,186.45
1,175,771.38
1,107,911.63
Total Expenses
4,199,351.77
4,275,334.94
4,259,848.19
4,302,997.32
4,331,468.82
Net Income from Continuing & Discontinued Operation
599,202.94
730,073.37
606,096.35
1,033,255.69
921,170.37
Normalized Income
837,498.48
990,299.75
804,075.50
1,121,416.67
991,926.59
Interest Income
26,158.61
41,316.67
86,063.89
91,824.26
13,204.07
Interest Expense
7,752.41
10,124.31
19,377.42
21,733.60
22,375.56
Net Interest Income
-12,147.08
29,460.02
65,332.90
66,616.03
-10,857.17
EBIT
775,282.79
929,575.71
749,979.84
1,202,375.64
1,126,197.23
EBITDA
775,282.79
1,351,390.12
1,160,596.95
1,584,193.98
1,474,394.76
Reconciled Cost of Revenue
3,392,949.47
3,478,574.74
3,417,168.67
3,443,493.39
3,557,815.87
Reconciled Depreciation
420,415.30
421,814.40
410,617.11
381,818.34
348,197.53
Net Income from Continuing Operation Net Minority Interest
599,202.94
730,073.37
606,096.35
1,033,255.69
921,170.37
Total Unusual Items Excluding Goodwill
-311,674.09
-328,416.39
-238,266.82
-100,920.51
-84,804.02
Total Unusual Items
-311,674.09
-328,416.39
-238,266.82
-100,920.51
-84,804.02
Normalized EBITDA
1,086,956.88
1,679,806.51
1,398,863.77
1,685,114.48
1,559,198.78
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-73,378.55
-68,190.02
-40,287.67
-12,759.52
-14,047.80
12/31/2022 - 10/10/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: